Home/Recalls/CANADA-77668
Health CanadaType I

RIVA-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit fo...

Published: July 3, 2025Recall ID: 77668Category: generalCountry: Canada

Reason for Recall / Hazard

Product quality

Product Description & Identification

Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.

Affected Products

RIVA-Fluoxetine 10 mg capsule

Additional Source Details

FieldValue
N I D77668
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/riva-fluoxetine-10-mg-capsule-may-exceed-interim-acceptable-intake-limit-n-nitroso
IssueProduct quality
TitleRIVA-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetine
ProductRIVA-Fluoxetine 10 mg capsule
Archived0
CategoryDrugs
Last updated2025-07-03
OrganizationDrugs and health products
Recall classType I
What you should doVerify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.

Overview

  • Recalling FirmDrugs and health products
  • Risk LevelType I
Official Agency Alert